ADVAITA CORP
A computational platform for analyzing single-cell genomic data that identifies cell types, infers developmental trajectories, and deconvolves bulk expression data using reference datasets and pathway
- Sector
- Biotech
- Total capital
- $4.4M
- Federal grants
- $4.3M
- 7 awards · 2015–2024
- Rank in peer group#14 of 28
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $97K
- 5 awards · Health and Human S, Agriculture
- Rank in Biotech#332 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis$897K
- Federal grantHealth and Human S · Phase II · A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis$878K
- Federal grantNSF · Phase I · SBIR Phase I: A knowledge base and drug repurposing platform for COVID-19$256K
- Federal grantNSF · Phase II · SBIR Phase II: A multi-omics data integration approach for precision medicine and improved clinical trial success$857K
- Federal contractAgriculture · Ipathwayguide Software License (2549)$5K
- Federal contractHealth and Human S · ADVAITA,CORP:1127240 [17-058375]$25K
- Federal grantNSF · Phase I · SBIR Phase I: A multi-omics data integration approach for precision medicine and improved clinical trial success$225K
Show 5 earlier federal awards
- Federal contractAgriculture · Ipathwayguide (2078)$5K
- Federal contractHealth and Human S · ADVAITA,CORP:1127240 [16-048496]$20K
- Federal grantHealth and Human S · Phase II · Pathway analysis tools for personalized medicine and drug repositioning$587K
- Federal grantHealth and Human S · Phase II · Pathway analysis tools for personalized medicine and drug repositioning$587K
- Federal contractHealth and Human S · To Provide Bioinformatics Consulting Services In The Prb/nih Housed At Hutzel Hospital, Detoit, Mi. 07/01/08-06/30/09$43K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 28 peers
Line = medianBiotech · Software
- Federal grants#14 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- EXEMPLAR GENETICS, LLCSimilar federal contract value in Biotech · $101K in contracts
- SYNZYME TECHNOLOGIES LLCSimilar federal contract value in Biotech · $100K in contracts
- B-MoGen Biotechnologies IncSimilar federal contract value in Biotech · $100K in contracts
- Data2Discovery IncSimilar federal contract value in Biotech · $97K in contracts
- FLUENT BIOSCIENCES INCSimilar federal contract value in Biotech · $96K in contracts
- Bellbrook Labs, LLCSimilar federal contract value in Biotech · $90K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .